PROMIS NEUROSCIENCES INC. Deferred Compensation Liability, Current
PROMIS NEUROSCIENCES INC. (PMN) had Deferred Compensation Liability, Current of $1.40 million as of 2021-12-31, per its 10-K filed 2023-03-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Compensation Liability, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2023-03-08
- 2021-12-31: Deferred Compensation Liability, Current $1.40M.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2021-12-31 | $1.40M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |